Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 02:31:21 UTC 2023
by
admin
on
Sat Dec 16 02:31:21 UTC 2023
|
| Protein Type | HORMONE |
| Protein Sub Type | |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
SQ6SA9L9XQ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
16131070
Created by
admin on Sat Dec 16 02:31:21 UTC 2023 , Edited by admin on Sat Dec 16 02:31:21 UTC 2023
|
PRIMARY | |||
|
89750-14-1
Created by
admin on Sat Dec 16 02:31:21 UTC 2023 , Edited by admin on Sat Dec 16 02:31:21 UTC 2023
|
ALTERNATIVE | |||
|
GLUCAGON-LIKE PEPTIDE-1
Created by
admin on Sat Dec 16 02:31:21 UTC 2023 , Edited by admin on Sat Dec 16 02:31:21 UTC 2023
|
PRIMARY | |||
|
DTXSID10236651
Created by
admin on Sat Dec 16 02:31:21 UTC 2023 , Edited by admin on Sat Dec 16 02:31:21 UTC 2023
|
PRIMARY | |||
|
D052216
Created by
admin on Sat Dec 16 02:31:21 UTC 2023 , Edited by admin on Sat Dec 16 02:31:21 UTC 2023
|
PRIMARY | |||
|
SUB179551
Created by
admin on Sat Dec 16 02:31:21 UTC 2023 , Edited by admin on Sat Dec 16 02:31:21 UTC 2023
|
PRIMARY | |||
|
87805-34-3
Created by
admin on Sat Dec 16 02:31:21 UTC 2023 , Edited by admin on Sat Dec 16 02:31:21 UTC 2023
|
PRIMARY | |||
|
SQ6SA9L9XQ
Created by
admin on Sat Dec 16 02:31:21 UTC 2023 , Edited by admin on Sat Dec 16 02:31:21 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVATOR OF EXPRESSION->TARGET |
Acarbose treatment stimulates postprandial GLP-1 secretion in patients with type 2 diabetes. Dependent on dose and saccharide or polysaccharide present. A single dose of 100 mg acarbose during an oral sucrose (disaccharide) load resulted in elevated GLP-1 levels compared to placebo (8, 10, 28, 29) whereas no effect was seen during oral glucose tolerance test (24), emphasizing that acarbose needs relevant carbohydrates to ‘act on’ in order to increase GLP-1 secretion. A single dose of 100 mg acarbose during an oral sucrose (disaccharide) load resulted in elevated GLP-1 levels compared to placebo (8, 10, 28, 29) whereas no effect was seen during oral glucose tolerance test (24), emphasizing that acarbose needs relevant carbohydrates to ‘act on’ in order to increase GLP-1 secretion.
|
||
|
|
AGONIST -> TARGET |
|
||
|
AGONIST -> TARGET |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|